Results 191 to 200 of about 83,737 (309)

Risk-adjusted Precision Reconstruction in Gastric Outlet Obstruction: A Prospective Cohort Demonstrating Superior Composite Delayed Gastric Emptying Outcomes with Roux-En-Y Gastrojejunostomy. [PDF]

Int J Appl Basic Med Res
Saini T, Singla S, Kumar S, Singh RK, Kumar S, Mandal M, Raj AK, Sidhu MS.   +7 more
europepmc   +1 more source

Dermatological Manifestations of Glucagon‐Like Peptide‐1 Receptor Agonists

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‑1 RAs) play a pivotal role in treating type 2 diabetes. Despite their widespread use, their dermatological manifestations remain under‐recognized, hence the interest of this systematic review. Objectives This systematic review aims to assess dermatological manifestations associated with
Nour Ghostine, Maya Halabi‐Tawil
wiley   +1 more source

Delayed Gastric Emptying After Classical Pancreaticoduodenectomy Versus Pylorus-Preserving Pancreaticoduodenectomy With Billroth II Retrocolic Reconstruction in Patients With Cancer. [PDF]

Cureus
Gamboa-Hoil SI, Gamboa-Gutiérrez R, Medina-Campos A.   +2 more
europepmc   +1 more source

Persistence of abnormal gastrointestinal motility after operation for Hirschsprung's disease [PDF]

, 2000
CLOUSE RE, ESPOSITO C, MIELE, ERASMO, STAIANO, ANNAMARIA, TORALDO C, TOZZI A   +5 more
core   +1 more source

USP54 Promotes Ferroptosis in Non‐Small Cell Lung Cancer by Mediating FOXA2 Deubiquitination and Enhancing ACSL4 Transcription

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Non‐small cell lung cancer (NSCLC) is the most common type of lung cancer, with a 5‐year survival rate of less than 20% and a high risk of recurrence despite advances in treatment. This study aimed to identify new therapeutic targets to increase the effectiveness of NSCLC treatments.
Rui‐Shi Wei, Yong‐Ping Liu, Chun‐Dong Gu, Shi‐Lei Zhao, Li Feng, Jian‐Rong Yu   +5 more
wiley   +1 more source

Gastric peroral endoscopic pyloromyotomy as an effective treatment for symptomatic delayed gastric emptying after Ivor Lewis esophagectomy. [PDF]

IGIE
Nammour T, Nishimura M, Zbib N, Lee SE, Nagao S, Koseki M, Molena D, Jones DR, Gerdes H, Beauvais J, Schattner M.   +10 more
europepmc   +1 more source

Fat Mass and Obesity‐Associated Protein Contributes to Tumorigenesis and Drug Resistance of Diffuse Large B‐Cell Lymphoma by Suppressing N6‐Methyladenosine Methylation of Myc

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Ibrutinib resistance remains a major obstacle in the treatment of diffuse large B‐cell lymphoma (DLBCL). Fat mass and obesity‐associated protein (FTO) has been implicated in drug resistance through its regulation of N6‐methyladenosine (m6A) modifications; however, whether FTO mediates ibrutinib resistance in DLBCL remains unclear.
Ting‐Ting Lu, Jin‐Hao Chen, Yan‐Fang Wang, Xiao Wu, Hui‐Yun Ni, Qiu‐Rong Zhang   +5 more
wiley   +1 more source

Effect of exercise prescription intervention mode in the Omaha System in elderly patients with delayed gastric emptying after choledocholithiasis surgery. [PDF]

Front Surg
Kan W, Sun H, Chen R.
europepmc   +1 more source

Obesity and gastric emptying

Gastroenterology, 1983
openaire   +2 more sources

Metabolic Dysfunction‐Associated Steatotic Liver Disease and Obesity: Pathogenesis, Diagnostics, Risk Stratification, and Therapeutic Approach

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) has emerged as the most prevalent chronic liver disease worldwide, closely linked to the global rising incidence of obesity and metabolic syndrome. This review synthesizes current evidence on the pathogenesis, gut–liver axis, and multidisciplinary management of MASLD within the ...
Beom Kyung Kim
wiley   +1 more source